India's economy has failed to generate enough jobs for its large and expanding young population
India's Serum Institute seeks emergency use nod for AstraZeneca's COVID-19 vaccine
The Serum Institute of India has sought emergency use authorisation from India's drug regulator for AstraZeneca Plc's COVID-19 vaccine on Sunday, according to several reports in Indian media, citing PTI.
Published : 7 Dec 2020, 03:05 AM
Updated : 7 Dec 2020, 03:05 AM
It applied to the Drugs Controller General of India, citing unmet medical needs due to the pandemic and in the interest of the public at large, the agency report said, citing official sources.
The Serum Institute was not immediately available to Reuters request for comment.
RELATED STORIES
The "temporary retreat" comes after the return of junta soldiers to the vital strategic area that is a conduit for annual foreign trade of more than $1 billion
This year demand is above average as heatwaves and election rallies boost consumption of ice-cream and soft drinks, a mill official says
Singapore has also ordered a recall of the Everest spice mix and advised against its consumption
